Metraipolis › archive › dc_aefcf8f0ee88

Hidden asymptomatic breakthrough infection in a proof-of-concept longitudinal study on SARS-CoV-2 vaccine recipients — Europe PMC PMID:42487117

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42487117
DOI
10.1186/s12929-[numero omesso]-5
License (as archived)
solo-consultazione
Archived
2026-10-17T22:57:00.258Z
SHA-256 of the archived text
40a0282fed44ce678cd87a19b5b20c7536e5effa007f68333801157532c858b9
Stable URL of this page
https://metraipolis.com/documento/dc_aefcf8f0ee88

How to cite

Hidden asymptomatic breakthrough infection in a proof-of-concept longitudinal study on SARS-CoV-2 vaccine recipients — Europe PMC PMID:42487117 — Europe PMC (en), https://europepmc.org/article/MED/42487117 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_aefcf8f0ee88 (Metraipolis archive dc_aefcf8f0ee88, sha256 40a0282fed44ce678cd87a19b5b20c7536e5effa007f68333801157532c858b9)
BibTeX
@misc{dcaefcf8f0ee88,
  title = {Hidden asymptomatic breakthrough infection in a proof-of-concept longitudinal study on SARS-CoV-2 vaccine recipients — Europe PMC PMID:42487117},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42487117},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_aefcf8f0ee88; sha256 40a0282fed44ce678cd87a19b5b20c7536e5effa007f68333801157532c858b9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42487117. Agents can read the archived copy with the MCP tool read_document.